HU210818A9 - Pressurised aerosol compositions - Google Patents

Pressurised aerosol compositions

Info

Publication number: HU210818A9
Authority: HU; Hungary
Prior art keywords: pressurised aerosol; units; aerosol compositions; liquefied hydrofluoroalkane; containing units
Prior art date: 1991-09-25

Application number

HU95P/P00090P

Other languages

English (en)

Inventor

Mark Gibson

Suresh Nagarbhai Mistry

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-25

Filing date

1995-03-20

Publication date

1995-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU210818(A9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-09-25 Priority claimed from GB919120396A external-priority patent/GB9120396D0/en

1991-09-28 Priority claimed from GB919120675A external-priority patent/GB9120675D0/en

1991-11-19 Priority claimed from GB919124661A external-priority patent/GB9124661D0/en

1992-02-14 Priority claimed from GB929203212A external-priority patent/GB9203212D0/en

1995-03-20 Application filed by Fisons Plc filed Critical Fisons Plc

1995-08-28 Publication of HU210818A9 publication Critical patent/HU210818A9/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Otolaryngology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Colloid Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

HU95P/P00090P 1991-09-25 1995-03-20 Pressurised aerosol compositions HU210818A9 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB919120396A GB9120396D0 (en)	1991-09-25	1991-09-25	Formulations
GB919120675A GB9120675D0 (en)	1991-09-28	1991-09-28	Formulation
GB919124661A GB9124661D0 (en)	1991-11-19	1991-11-19	Formulations
GB929203212A GB9203212D0 (en)	1992-02-14	1992-02-14	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
HU210818A9 true HU210818A9 (en)	1995-08-28

Family

ID=27450754

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HU9400853A HUT67480A (en)	1991-09-25	1992-09-23	Pressurised aerosol inhalation compositions
HU95P/P00090P HU210818A9 (en)	1991-09-25	1995-03-20	Pressurised aerosol compositions

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HU9400853A HUT67480A (en)	1991-09-25	1992-09-23	Pressurised aerosol inhalation compositions

Country Status (29)

Country	Link
US (1)	US6641800B1 (hu)
EP (2)	EP0605578B2 (hu)
JP (1)	JP3142136B2 (hu)
KR (1)	KR100275426B1 (hu)
CN (1)	CN1050285C (hu)
AT (1)	ATE132739T1 (hu)
AU (1)	AU654397B2 (hu)
BG (1)	BG61752B1 (hu)
BR (1)	BR9206549A (hu)
CA (1)	CA2119932C (hu)
CZ (1)	CZ282506B6 (hu)
DE (1)	DE69207606T3 (hu)
DK (1)	DK0605578T4 (hu)
ES (1)	ES2082507T5 (hu)
FI (1)	FI110407B (hu)
GR (2)	GR3019098T3 (hu)
HK (1)	HK1005564A1 (hu)
HU (2)	HUT67480A (hu)
IL (1)	IL103238A (hu)
MX (1)	MX9205483A (hu)
MY (1)	MY108309A (hu)
NO (1)	NO307124B1 (hu)
NZ (1)	NZ244439A (hu)
RO (1)	RO114735B1 (hu)
RU (1)	RU2122852C1 (hu)
SK (1)	SK279456B6 (hu)
TW (1)	TW216442B (hu)
UA (1)	UA41873C2 (hu)
WO (1)	WO1993005765A1 (hu)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
GB9214819D0 (en) *	1992-07-13	1992-08-26	Minnesota Mining & Mfg	Valve assemblies
AU679511B2 (en) *	1993-03-17	1997-07-03	Minnesota Mining And Manufacturing Company	Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
NZ263410A (en) *	1993-03-17	1997-05-26	Minnesota Mining & Mfg	Pharmaceutical aerosol containing diol-diacid derived dispersing aid
DE59609627D1 (de)	1995-06-27	2002-10-10	Boehringer Ingelheim Pharma	Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
US6039932A (en) *	1996-09-27	2000-03-21	3M Innovative Properties Company	Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) *	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US6433040B1 (en)	1997-09-29	2002-08-13	Inhale Therapeutic Systems, Inc.	Stabilized bioactive preparations and methods of use
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en)	1997-09-29	2005-09-20	Nektar Therapeutics	Stabilized preparations for use in nebulizers
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6136294C1 (en) *	1998-09-22	2002-09-24	Aeropharm Technology Inc	Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) *	2000-01-25	2003-04-01	Aeropharm Technology Incorporated	Medical aerosol formulation
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
JP2003531123A (ja) *	2000-04-13	2003-10-21	イノバータ・バイオミッド・リミテッド	医薬品
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
TWI290473B (en)	2000-05-10	2007-12-01	Alliance Pharma	Phospholipid-based powders for drug delivery
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2411047C (en)	2000-05-22	2009-08-04	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
SI1273292T1 (en)	2001-07-02	2004-12-31	Chiesi Farmaceutici S.P.A.	Optimised formulation of tobramycin for aerosolization
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
ES2364636T3 (es)	2001-12-19	2011-09-08	Novartis Ag	Administración pulmonar de aminoglucósidos.
US7544177B2 (en) *	2002-01-24	2009-06-09	The Regents Of The University Of California	Aerosol device to deliver bioactive agent
SE0200312D0 (sv) *	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
US7244742B2 (en) *	2002-08-17	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co Kg	Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) *	2003-12-10	2004-01-14	Medpharm Ltd	Metered dose inhalation preparations
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7994225B2 (en) *	2004-03-17	2011-08-09	Rempex Pharmaceuticals, Inc.	Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
EP1732527A2 (en) *	2004-03-17	2006-12-20	Mpex Pharmaceuticals, Inc.	Use and administration of bacterial efflux pump inhibitors
US20070031343A1 (en) *	2005-08-04	2007-02-08	Bonfour Charles A Iii	Flavored medicinal inhalant
FR2895260B1 (fr) *	2005-12-23	2009-02-20	Servier Lab	Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) *	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2120875B1 (en)	2007-02-11	2018-07-11	Map Pharmaceuticals Inc.	Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2008152398A2 (en) *	2007-06-14	2008-12-18	Cipla Limited	Formulations for inhalation
GB0712454D0 (en)	2007-06-27	2007-08-08	Generics Uk Ltd	Pharmaceutical compositions
AU2009244462B2 (en)	2008-05-06	2013-04-11	Cook Medical Technologies Llc	Apparatus and methods for delivering therapeutic agents
BRPI0916047A2 (pt) *	2008-11-04	2015-11-10	Cipla Ltd	composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante
US8361054B2 (en)	2008-12-23	2013-01-29	Cook Medical Technologies Llc	Apparatus and methods for containing and delivering therapeutic agents
US9101744B2 (en)	2009-05-29	2015-08-11	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
US8118777B2 (en)	2009-05-29	2012-02-21	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
CN102416179B (zh)	2010-09-28	2014-05-07	益得生物科技股份有限公司	用于哮喘的吸入性复方组合物
US9867931B2 (en)	2013-10-02	2018-01-16	Cook Medical Technologies Llc	Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en)	2013-03-15	2024-03-19	Cook Medical Technologies Llc	Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) *	2014-02-13	2014-04-02	Cardiff Scintigraphics Ltd	Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en)	2014-07-29	2016-02-04	3M Innovative Properties Company	Method of preparing a pharmaceutical composition
CN108135840A (zh) *	2015-10-23	2018-06-08	巴斯夫欧洲公司	用于皮肤施用的控释香精的配制剂
US10702495B2 (en)	2017-02-20	2020-07-07	Nexien Biopharma, Inc.	Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en)	2019-06-11	2020-12-16	Nexien Biopharma, Inc.	Compositions for treating dystrophies and myotonia
WO2021247850A2 (en)	2020-06-05	2021-12-09	Cook Medical Technologies Llc	Medical scopes for delivering therapeutic agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US417295A (en) *		1889-12-17		Fabriken
AT274245B (de)	1967-05-17	1969-09-10		Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en)	1972-09-06	1977-05-24	Burroughs Wellcome Co.	Cyclic sulphur compounds
CA1136547A (en) *	1979-03-08	1982-11-30	Song-Ling Lin	Aerosol anesthetic compositions
EP0175671A1 (de)	1984-08-23	1986-03-26	Kuhlemann & Co.	Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
JP2573275B2 (ja)	1986-03-10	1997-01-22	ブルグハルト，クルト	薬学的製剤及びその製造法
JPS63503304A (ja) *	1986-03-10	1988-12-02	ブルグハルト，クルト	医薬製剤およびその製造方法
US4752466A (en)	1987-08-31	1988-06-21	Johnson & Johnson Products, Inc.	Thrombin aerosol
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
US5225183A (en)	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
GB8921222D0 (en)	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IL95952A0 (en)	1989-10-19	1991-07-18	Sterling Drug Inc	Aerosol composition for topical medicament
IL97065A (en)	1990-02-02	1994-01-25	Fisons Plc	Repellent preparations for aerosol
US6123924A (en) *	1991-09-25	2000-09-26	Fisons Plc	Pressurized aerosol inhalation compositions
US5658549A (en)	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) *	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery

1992
- 1992-09-22 IL IL10323892A patent/IL103238A/en not_active IP Right Cessation
- 1992-09-22 NZ NZ244439A patent/NZ244439A/en not_active IP Right Cessation
- 1992-09-23 JP JP05505930A patent/JP3142136B2/ja not_active Expired - Fee Related
- 1992-09-23 EP EP92920611A patent/EP0605578B2/en not_active Expired - Lifetime
- 1992-09-23 CA CA002119932A patent/CA2119932C/en not_active Expired - Lifetime
- 1992-09-23 HU HU9400853A patent/HUT67480A/hu unknown
- 1992-09-23 AT AT92920611T patent/ATE132739T1/de active
- 1992-09-23 UA UA94005331A patent/UA41873C2/uk unknown
- 1992-09-23 RU RU94022269/14A patent/RU2122852C1/ru active
- 1992-09-23 AU AU26471/92A patent/AU654397B2/en not_active Expired
- 1992-09-23 KR KR1019940700969A patent/KR100275426B1/ko not_active Expired - Lifetime
- 1992-09-23 ES ES92920611T patent/ES2082507T5/es not_active Expired - Lifetime
- 1992-09-23 MY MYPI92001697A patent/MY108309A/en unknown
- 1992-09-23 BR BR9206549A patent/BR9206549A/pt not_active Application Discontinuation
- 1992-09-23 WO PCT/GB1992/001749 patent/WO1993005765A1/en active IP Right Grant
- 1992-09-23 EP EP92308657A patent/EP0534731A1/en active Pending
- 1992-09-23 CZ CZ94695A patent/CZ282506B6/cs not_active IP Right Cessation
- 1992-09-23 DE DE69207606T patent/DE69207606T3/de not_active Expired - Lifetime
- 1992-09-23 DK DK92920611T patent/DK0605578T4/da active
- 1992-09-23 RO RO94-00492A patent/RO114735B1/ro unknown
- 1992-09-23 SK SK340-94A patent/SK279456B6/sk not_active IP Right Cessation
- 1992-09-25 MX MX9205483A patent/MX9205483A/es unknown
- 1992-09-25 CN CN92112491A patent/CN1050285C/zh not_active Expired - Lifetime
- 1992-09-29 TW TW081107686A patent/TW216442B/zh not_active IP Right Cessation
1994
- 1994-03-24 BG BG98681A patent/BG61752B1/bg unknown
- 1994-03-24 NO NO941077A patent/NO307124B1/no not_active IP Right Cessation
- 1994-03-25 FI FI941388A patent/FI110407B/fi not_active IP Right Cessation
1995
- 1995-03-20 HU HU95P/P00090P patent/HU210818A9/hu unknown
1996
- 1996-02-23 GR GR960400518T patent/GR3019098T3/el unknown
1998
- 1998-05-29 HK HK98104659A patent/HK1005564A1/xx not_active IP Right Cessation
1999
- 1999-12-10 GR GR990403193T patent/GR3032103T3/el unknown
2000
- 2000-07-13 US US09/616,069 patent/US6641800B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0605578B1 (en)	1996-01-10
KR100275426B1 (ko)	2001-03-02
JP3142136B2 (ja)	2001-03-07
FI941388A0 (fi)	1994-03-25
CZ282506B6 (cs)	1997-07-16
RU2122852C1 (ru)	1998-12-10
BG61752B1 (bg)	1998-05-29
GR3019098T3 (en)	1996-05-31
DK0605578T3 (da)	1996-03-25
EP0534731A1 (en)	1993-03-31
BG98681A (bg)	1995-02-28
CA2119932C (en)	2002-05-21
MY108309A (en)	1996-09-30
ATE132739T1 (de)	1996-01-15
AU2647192A (en)	1993-04-27
HUT67480A (en)	1995-04-28
NO307124B1 (no)	2000-02-14
US6641800B1 (en)	2003-11-04
RO114735B1 (ro)	1999-07-30
NZ244439A (en)	1994-01-26
BR9206549A (pt)	1995-10-17
AU654397B2 (en)	1994-11-03
MX9205483A (es)	1993-05-01
DE69207606T2 (de)	1996-06-27
NO941077L (no)	1994-05-18
WO1993005765A1 (en)	1993-04-01
ES2082507T5 (es)	1999-11-16
UA41873C2 (uk)	2001-10-15
GR3032103T3 (en)	2000-03-31
NO941077D0 (no)	1994-03-24
FI941388L (fi)	1994-03-25
HK1005564A1 (en)	1999-01-15
EP0605578B2 (en)	1999-09-22
CA2119932A1 (en)	1993-04-01
DK0605578T4 (da)	2000-03-06
EP0605578A1 (en)	1994-07-13
JPH07502262A (ja)	1995-03-09
TW216442B (en)	1993-11-21
SK34094A3 (en)	1994-11-09
DE69207606T3 (de)	2000-03-16
CN1071832A (zh)	1993-05-12
CZ69594A3 (en)	1995-11-15
SK279456B6 (sk)	1998-11-04
IL103238A0 (en)	1993-02-21
DE69207606D1 (de)	1996-02-22
FI110407B (fi)	2003-01-31
ES2082507T3 (es)	1996-03-16
IL103238A (en)	1995-07-31
CN1050285C (zh)	2000-03-15
HU9400853D0 (en)	1994-06-28

Publication	Publication Date	Title
IL103238A0 (en)	1993-02-21	Pressurised aerosol compositions
CA2156075A1 (en)	1994-09-29	Aerosol formulation containing a dispersing aid
CA2142126A1 (en)	1994-03-03	Inhalation powder containing antistatic agent
EP0647133A4 (en)	1997-10-29	COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY.
EP0701457A4 (en)	1997-12-17	SYSTEMS FOR INTERPULMONARY ADMINISTRATION OF AQUEOUS SOLUTIONS
AU6130694A (en)	1994-08-15	An automatic aerosol medication delivery system and methods
ZA949378B (en)	1995-08-11	A medicinal aerosol formulation
ZA941002B (en)	1994-09-30	Pharmaceutical compositions in semisold form and a device for administration thereof
ZA926019B (en)	1993-03-10	Pharmaceutical spheroid formulation.
EP0698631A3 (en)	1996-09-11	Copolyester resin, polymer mixture and packaging material made of it
AU1162892A (en)	1992-08-27	Metered dose atomising and delivery device
AU6484594A (en)	1995-01-05	Cryogenic storage and delivery method and apparatus
AU7115791A (en)	1991-09-26	Cryogen delivery apparatus
AU8068294A (en)	1995-05-23	Gas pressurized liquid delivery system
IL110809A0 (en)	1994-11-11	1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them
HUP0000084A3 (en)	2001-12-28	3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them
ES2064244A1 (es)	1995-01-16	Composiciones de aerosol presurizadas.
GR1001487B (el)	1994-02-28	Πεπιεσμένες συν?έσεις αεροζόλης.
IL109436A0 (en)	1994-07-31	Quinolyl-dihydropyridine esters, processes for their preparation, and their use in pharmaceutical compositions
HUT75711A (en)	1997-05-28	The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
AU1104192A (en)	1992-08-06	Bulk delivery and storage wood-bin
IL124423A0 (en)	1998-12-06	Pharmaceutical composition comprising an active compound in a polymer
GB9315411D0 (en)	1993-09-08	Active agent delivery
CA2249637A1 (en)	1997-10-16	Uniform drug delivery therapy
IL122673A0 (en)	1998-08-16	10-substituted 1,8-dihydroxy-9-(10H) anthracenones and pharmaceutical compositions containing